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Fire safety standards, including the application 
of flame-retardant chemicals, have been estab-
lished in modern societies to reduce deaths and 
injuries as well as economic impact of fires. 
Bromine, like other halogens, quenches free 
radicals generated in a fire with high efficiency, 
thereby preventing the propagation of a flame. 
In Europe and North America, brominated 
flame retardants (BFRs) are therefore com-
monly used in household applications. BFRs 
were established as the major chemical flame 
retardant in the 1970s after the discovery of 
the adverse effects of polychlorinated biphenyls 
(PCBs) on human and environ  mental health 
and in experimental studies (for reviews, see 
Fonnum and Mariussen 2009; Seegal 1996). 
BFRs are a structurally diverse group of chemi-
cals, with polybrominated diphenyl ethers 
(PBDEs) (Table 1) being among the formerly 
most highly produced BFRs (Bromine Science 
and Environmental Forum 2010).
Although PBDEs are globally dispersed 
throughout the environment (reviewed by 
Law et al. 2008), human and environmental 
levels of PBDEs are approximately one order 
of magnitude higher in North America than 
in Europe and Asia (reviewed by Frederiksen 
et al. 2009). Humans are exposed to PBDEs in 
particular via air and ingestion of house dust, 
but also through intake of vegetable and ani-
mal products (reviewed by Frederiksen et al. 
2009). Because of their relatively high food 
intake, child-specific hand-to-mouth behav-
ior, and frequent ground contact (resulting 
in the ingestion of house dust), children are 
exposed to larger amounts of PBDEs than are 
adults (Fischer et al. 2006; Toms et al. 2009). 
An additional source of exposure for young 
children is breast milk, in which especially 
lower brominated PBDEs have been detected 
(reviewed by Frederiksen et al. 2009). Prenatal 
exposure to PBDEs occurs through placental 
transfer [Gómara et al. 2007; Mazdai et al. 
2003; see Supplemental Material, Table 1 
(doi:10.1289/ehp.1003035)].
Toxicokinetics studies have revealed the 
formation of methoxylated (MeO-) and 
hydroxylated (OH-)PBDEs in vivo (Malmberg 
et al. 2005; Staskal et al. 2006b; Wan 
et al. 2009; see also Supplemental Material 
(doi:10.1289/ehp.1003035)] and in vitro 
(Hamers et al. 2008; Stapleton et al. 2009; 
Wan et al. 2009). Interestingly, OH-PBDEs 
and MeO-PBDEs have also been detected 
as natural products in marine algae, cyano-
bacteria, and sponges (e.g., Malmvärn et al. 
2008; Teuten et al. 2005). Human exposure 
studies have revealed that various OH-PBDEs 
are present in serum at concentrations similar 
to or sometimes higher than those of parent 
PBDEs (Athanasiadou et al. 2008; Qiu et al. 
2009; see Supplemental Material, Table 1).
Since the start of this century, exposure 
to BFRs has been associated with (develop-
mental) neuro  toxicity (Eriksson et al. 2001). 
Recently, adverse effects on cognitive and 
neuro  developmental parameters in humans 
were correlated to exposure to PBDEs. Motor, 
cognitive, and behavioral performance in 
6-year-old Dutch children was correlated with 
maternal serum levels of PBDEs meas  ured in 
the 35th week of pregnancy (Roze et al. 2009). 
In another study, the scores of U.S. children 
0–6 years of age on yearly tests of mental and 
physical develop  ment were lower among those 
prenatally exposed to higher concentrations of 
PBDEs (Herbstman et al. 2010).
In this review we extend knowledge from 
previous reviews of under  lying mecha  nisms 
of adverse effects on the nervous system by 
exposure to PBDEs (Costa and Giordano 
2007; Fonnum and Mariussen 2009) and 
also focus on the contribution of OH-PBDEs 
to PBDE-induced neuro  toxicity.
Toxicity of PBDEs: 
Target Organs
Early acute in vivo toxicity studies have 
revealed only moderate effects of PBDEs 
at high exposure concentrations, mainly in 
the liver and thyroid gland (Hardy 2002). 
The first studies on the toxic mechanisms of 
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Ba c k g r o u n d/o B j e c t i v e: Polybrominated diphenyl ethers (PBDEs) and their hydroxylated (OH-) 
or methoxylated forms have been detected in humans. Because this raises concern about adverse 
effects on the developing brain, we reviewed the scientific literature on these mechanisms. 
da t a synthesis: Many rodent studies reported behavioral changes after developmental, neo-
natal, or adult exposure to PBDEs, and other studies documented subtle structural and functional 
alterations in brains of PBDE-exposed animals. Functional effects have been observed on synaptic 
plasticity and the glutamate–nitric oxide–cyclic guanosine monophosphate pathway. In the brain, 
changes have been observed in the expression of genes and proteins involved in synapse and axon 
formation, neuronal morphology, cell migration, synaptic plasticity, ion channels, and vesicular 
neuro  transmitter release. Cellular and molecular mechanisms include effects on neuronal viability   
(via apoptosis and oxidative stress), neuronal differentiation and migration, neuro  transmitter 
release/uptake, neuro  transmitter receptors and ion channels, calcium (Ca2+) homeo  stasis, and intra-
cellular signaling pathways. 
discussion: Bioactivation of PBDEs by hydroxylation has been observed for several endocrine end 
points. This has also been observed for mechanisms related to neuro  development, including binding 
to thyroid hormone receptors and transport proteins, disruption of Ca2+ homeo  stasis, and modula-
tion of GABA and nicotinic acetylcholine receptor function. 
co n c l u s i o n s: The increased hazard for developmental neuro  toxicity by hydroxylated (OH-)PBDEs 
compared with their parent congeners via direct neuro  toxicity and thyroid disruption clearly war-
rants further investigation into a ) the role of oxidative metabolism in producing active metabolites 
of PBDEs and their impact on brain development; b) concentrations of parent and OH-PBDEs in 
the brain; and c) inter  actions between different environmental contaminants during exposure to 
mixtures, which may increase neuro  toxicity.
key w o r d s : brominated flame retardant, calcium, developmental neuro  toxicity, PBDE, persistent 
organic pollutant, polybrominated diphenyl ether, structure–activity relationship, thyroid. Environ 
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PBDEs investigated the possible effects of 
PBDEs on aryl hydrocarbon receptor (AhR)-
mediated processes because of their structural 
resemblance to AhR-activating compounds 
(e.g., some PCBs). Although effects of PBDEs 
were detected on gene induction and activ-
ity of hepatic enzymes in vivo and in vitro 
(van den Berg et al. 2006), the observed 
AhR-mediated effects of commercial PBDE 
mixtures are now generally considered to be 
caused by trace amounts of brominated diox-
ins and furans, which are potent inducers of 
cytochrome P450 (CYP) 1A and 1B enzymes 
(Sanders et al. 2005; van den Berg et al. 2006; 
Wahl et al. 2008). A lack of activation of the 
AhR by PBDEs, probably because of their lack 
of a planar-like structure, was recently con-
firmed in primary hepato  cytes and hepatic cell 
lines (Wahl et al. 2010).
Endocrine and reproductive effects 
of PBDEs have been detected, in particular 
in wild birds and experimental studies with 
rodents (Dang et al. 2007; Fernie et al. 2008; 
Kuriyama et al. 2005). In epidemiological 
studies, exposure to PBDEs has been associated 
more recently with congenital cryptorchi  dism 
in Danish children (Main et al. 2007) and 
decreased fecundability (Harley et al. 2010).
In vitro studies have demonstrated that 
PBDEs and OH-PBDEs bind to estrogen, 
progesterone, androgen, and gluco  corticoid 
receptors and inhibit CYP enzymes involved 
in steroido  genesis (Table 2) (Kojima et al. 
2009; Meerts et al. 2001). Several studies have 
revealed that the potency of OH-PBDEs for 
these end points is higher than for their parent 
compounds, whereas MeO-PBDEs showed 
no or smaller effects (Table 2) (Cantón et al. 
2005, 2006; Hamers et al. 2006; Mercado-
Feliciano and Bigsby 2008).
Epidemiological studies also showed cor-
relations between human PBDE exposure and 
thyroid hormone levels (Chevrier et al. 2010; 
Turyk et al. 2008; Yuan et al. 2008). PBDEs 
and particularly OH-PBDEs structurally 
resemble the thyroid hormone thyroxin (T4) 
and have been found to bind to trans  thyretin 
(TTR), a thyroid hormone transport pro-
tein, and thyroid receptors α and β (Table 2) 
(Meerts et al. 2000). Effects of PBDEs and 
PBDE mixtures on the thyroid hormone 
system, mainly a decrease in T4 (hypothy-
roidism), were confirmed in vivo in rodents 
exposed pre  natally and/or neo  natally (Driscoll 
et al. 2009; Lee et al. 2010; Rice et al. 2007; 
Tseng et al. 2008; Zhou et al. 2001) or in 
adulthood (Darnerud et al. 2007; Richardson 
et al. 2008). Developmental exposure to low 
doses of BDE-47 (2,2´,4,4´-tetrabrominated 
diphenyl ether) resulted in changes in thy-
roid gland histology and morphology in rats 
(Talsness et al. 2008). In addition, a few stud-
ies found a reduction in the biologically active 
thyroid hormone tri  iodo  thyronine (T3) in 
serum of rats exposed to PBDEs (Lee et al. 
2010; Tseng et al. 2008). 
Neurotoxicity of PBDEs: 
Behavioral Effects
Eriksson et al. (2001) exposed mice to a 
single oral dose of BDE-47 and BDE-99 
(2,2´,4,4´,5-pentabrominated diphenyl ether) 
on post  natal day (PND) 10 and observed 
dose-dependent effects on spontaneous behav-
ior (loco  motion, rearing, and total activity) 
and Morris water maze relearning abilities 
of 2- and 4-month-old mice. Habituation 
capability also decreased with age in mice 
exposed to BDE-47 and BDE-99 compared 
with controls. This exposure regimen has been 
used to investigate effects of different PBDE 
congeners on spontaneous behavior. Similar 
long-lasting neurobehavioral changes have 
now been detected after a single oral dose 
of BDE-153 (2,2´,4,4´,5,5´-hexabrominated 
diphenyl ether), BDE-183 (2,2´,3,4,4´,5´,6-
hepta  brominated diphenyl ether), BDE-203 
(2,2´,3,4,4´,5,5´,6-octa  brominated diphenyl 
ether), BDE-206 (2,2´,3,3´,4,4´,5,5´,6-nona-
brominated diphenyl ether), or BDE-209 
(2,2´,3,3´,4,4´,5,5´,6,6´-deca  brominated 
diphenyl ether) adminis  tered to neo  natal mice 
(Johansson et al. 2008; Viberg et al. 2003, 
2006). Further research has demon  strated 
effects of PBDEs on behavioral end points 
and performance in learning tasks in rodents 
after neonatal adminis  tra  tion of a single oral 
dose, develop  mental exposure, or repeated 
neonatal dosing (Branchi et al. 2002; Dufault 
et al. 2005; Kuriyama et al. 2005). In a recent 
study, Cheng et al. (2009) reported impaired 
reflexes and Morris water maze relearning 
abilities in rats exposed to BDE-99 from 
gestation through lactation. Several devel-
opmental end points of motor activity and 
coordination were affected in mice exposed 
to a single oral dose of BDE-47 on PND10 
(Gee and Moser 2008). By operant condi-
tioning (reward-reinforced learning) of mice, 
increased impulsivity was observed in aging 
mice after neonatal exposure to BDE-209, 
whereas no effects were observed in litter-
mates tested during young adulthood (Rice 
et al. 2009). In another study, rats were 
chronically exposed to the commercial pent-
aBDE mixture DE-71 during lactation and 
through feed, which was continued through 
testing, to mimic low-level chronic human 
exposure (Driscoll et al. 2009); no effects 
were observed on operant conditioning in 
adult rats, although their attention spans were 
impaired. This impaired attention is consis-
tent with previously reported hyperactivity 
(i.e., increased loco  motor activity) in animals 
post  natally exposed to various PBDEs (e.g., 
Eriksson et al. 2001), although it may also be 
related to the presence of brominated dioxins 
and furans in this commercial PBDE mixture.
The aforementioned studies strongly sug-
gest that exposure to PBDEs causes adverse 
neuro  behavioral effects, in particular during 
early neuro  development. With respect to neo-
natal exposure, a study in which BDE-99 was 
administered on PND3, PND10, or PND19 
(Eriksson et al. 2002) revealed that brain 
development in mice is most sensitive to expo-
sure to PBDEs in the first 2 weeks after birth. 
In rats and mice, rapid growth of the brain, as 
well as synapto  genesis and myelination, occurs 
within these 2 weeks, whereas in humans these 
processes start in the last trimester of preg-
nancy and extend into early childhood (for 
reviews, see Dobbing and Sands 1979; Rice 
and Barone 2000; Tau and Peterson 2010).
Neurotoxicity of PBDEs: Effects 
on Brain Function and Structure
Using the same exposure regimen previously 
shown to affect neurobehavior (Eriksson et al. 
2001), Dingemans et al. (2007) found that 
neonatal exposure to BDE-47 impaired long-
term potentiation (LTP), a form of synaptic 
plasticity associated with learning and mem-
ory, measured ex vivo in hippocampal slices. 
Recently, Xing et al. (2009) reported that 
develop  mental exposure to the fully bromi-
nated BDE-209 also reduced LTP, as meas  ured 
in vivo in the dentate gyrus of the hippo  campus 
in rats. Rat offspring were exposed orally or 
via the mother to BDE-209 during different 
develop  mental periods (pregnancy, lactation, 
and after weaning). Decreases in synaptic plas-
ticity were related to hippocampal BDE-209 
concentrations, which were highest after intra-
gastric exposure during the lactational period 
compared with after exposure via the mother 
(gestational or via lactation) or directly to the 
pups after weaning (Xing et al. 2009).
Table 1. Individual PBDEs discussed in this review.
Abbreviation Name
BDE-47 2,2´,4,4´-Tetrabrominated 
diphenyl ether
BDE-49 2,2´,4,5´-Tetrabrominated 
diphenyl ether
BDE-99 2,2´,4,4´,5-Pentabrominated 
diphenyl ether
BDE-100 2,2´,4,4´,6-Pentabrominated 
diphenyl ether
BDE-153 2,2´,4,4´,5,5´-Hexabrominated 
diphenyl ether
BDE-183 2,2´,3,4,4´,5´,6-Heptabrominated 
diphenyl ether
BDE-203 2,2´,3,4,4´,5,5´,6-Octabrominated 
diphenyl ether
BDE-206 2,2´,3,3´,4,4´,5,5´,6-Nonabrominated 
diphenyl ether
BDE-209 2,2´,3,3´,4,4´,5,5´,6,6´-
Decabrominated diphenyl ether
DE-71 Commercial pentaBDE product
6-MeO-BDE-47 6-Methoxy-2,2´,4,4´-tetrabrominated 
diphenyl ether
6-OH-BDE-47 6-Hydroxy-2,2´,4,4´-tetrabrominated 
diphenyl etherDingemans et al.
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Developmental exposure [gestational 
days (GDs) 2–9] to BDE-99 resulted in 
increased activity of the glutamate–nitric 
oxide–cyclic guano  sine mono  phosphate path-
way in rat cerebellum (Llansola et al. 2007). 
This pathway is involved in the modulation 
of cerebral processes, including the release 
of neuro  transmitters and synaptic plastic-
ity (Boulton et al. 1995). Surprisingly, this 
increased activity coincided with a slightly 
enhanced performance in a learning task 
(Llansola et al. 2007).
Several studies have revealed effects of 
PBDEs on neuro  transmitter receptor function 
and brain protein levels (Table 3). Effects of 
PBDEs on the cholinergic neuro  transmitter 
system in rodents were revealed primarily by 
hypo  active responses to neuro  transmitter recep-
tor agonists (Johansson et al. 2008; Viberg et al. 
2002). Particularly in hippo  campus, but also 
in cortex and striatum, alterations in levels of 
key proteins involved in synaptic plasticity and 
brain development were detected after expo-
sure to PBDEs (Alm et al. 2006; Dingemans 
et al. 2007; Viberg et al. 2008). Effects were 
observed after exposure to either tetra- and 
pentaBDEs or octa- through decaBDEs.   
Potency differences between different PBDE 
congeners or degrees of bromination were 
not apparent.
Bellés et al. (2010) detected markers for 
oxidative stress in the cerebellum and, to a 
lesser extent, in cortex and hippo  campus of 
adult rats exposed to BDE-99 at 0.6 mg/kg 
body weight. In another study, Cheng et al. 
(2009) observed increased oxidative stress 
in the hippo  campus (not in cerebellum and 
cerebral cortex) of rats exposed from GD6 to 
PND21 to BDE-99 at 2 mg/kg body weight 
via their mother (transplacental and lacta-
tional exposure). Only in this study (Cheng 
et al. 2009) were behavioral effects detected as 
well— perhaps related to the higher dose, but 
more likely related to the timing of the expo-
sure (i.e., during neuro  development). 
Table 3. Effects of PBDE exposure on brain structure in rodents after oral administration during PNDs 1–14.
Species Effect PBDE
Effect concentration 
(μmol/kg body weight) Reference
C57Bl/6 mouse  Decreased GluR subunit NR2B, GluR subunit GluR1, and p286-αCaMKII 
in hippocampal PSD (Western blot)
BDE-47 14 Dingemans et al. 2007
NMRI mouse Decreased nAChR (decreased 3H-α-bungarotoxin binding)a BDE-99 21 Viberg et al. 2004
NMRI mouse Decreased nAChR (decreased 3H-α-bungarotoxin binding)a BDE-99 14 Viberg et al. 2002
NMRI mouse Alteration in hippocampal proteins (mainly proteins involved in 
metabolism and energy production, and in striatal proteins (mainly 
proteins involved in neuro  degeneration and neuroplasticity; proteomics)
BDE-99 21 Alm et al. 2006
NMRI mouse Alteration in cortical proteins (mainly cytoskeletal related; proteomics) BDE-99 21 Alm et al. 2008
NMRI mouse Decreased nAChR (decreased 3H-α-bungarotoxin binding)a BDE-153 14 Viberg et al. 2003
NMRI mouse Increased CaMKII and synaptophysin in hippocampus BDE-203 21 Viberg 2009a
NMRI mouse Increased CaMKII and synaptophysin in hippocampus BDE-206 21 Viberg 2009a
Sprague-Dawley rat Decreased nAChR (hypoactive in vivo nicotine response)a BDE-209 21 Viberg et al. 2007
NMRI mouse Decreased nAChR (hypoactive in vivo nicotine response)a BDE-209 14 Johansson et al. 2008
NMRI mouse Decreased BDNF and increased CaMKII and GAP-43 in hippocampus, 
decreased GAP-43 in cortex
BDE-209 21 Viberg et al. 2008
NMRI mouse Increased synaptophysin in hippocampus BDE-209 21 Viberg 2009b
Abbreviations: BDNF, brain-derived neurotrophic factor; CaMKII, Ca2+/calmodulin-dependent protein kinase II; GAP-43, growth-associated protein-43; GluR, glutamate receptor; nAChR, 
nACh receptor; p286-αCaMKII, autophosphorylated-active Ca2+/calmodulin-dependent protein kinase II; PSD, postsynaptic density. 
aEffects were detected on a whole-brain level. 
Table 2. Effects and effect concentrations of BDE-47, 6-OH-BDE-47, and 6-MeO-BDE-47.
Effect concentration (μM)
Test system (study) Effect Exposure duration BDE-47 6-OH-BDE-47 6-MeO-BDE-47
Human hepatoma (HepG2) cells (An et al. 2010) Reduced cell viability LOEC (72 hr) — 0.5 5
Cell cycle block LOEC (48 hr) — 0.5 NE (≤ 5)
ROS generation LOEC (24 hr) — 0.1 2
Human adrenocortical carcinoma (H296R) cells 
(Cantón et al. 2005, 2006) 
Reduced cell viability LOEC (24 hr) NE (≤ 7.5) 2.5 NE (≤ 7.5)
Aromatase activity inhibition LOEC (24 hr) NE (≤ 7.5) 2.5 5
CYP17 activity inhibition LOEC (24 hr) NE (≤ 10) 1 10
Human adrenocortical carcinoma (H296R) cells 
(Song et al. 2008)
Reduced cell viability LOEC (48 hr) NE (≤ 0.5) NE (≤ 0.5) NE (≤ 0.5)
Aromatase activity inhibition LOEC (48 hr) NE (≤ 0.5) NE (≤ 0.5) NE (≤ 0.5)
Human placental microsomes (Cantón et al. 2008) Aromatase activity inhibition IC50 (40 min) — 7.44 NE (≤ 40)
Nuclear hormone receptors transfected in CALUX 
cell lines (Hamers et al. 2006)
AhR EC50 (24 hr) NE (≤ 10) 1.3 ± 0.4 —
AhR IC50 (24 hr) 2.7 ± 0.7 NE (≤ 10) —
Androgen receptor IC50 (24 hr) 1.0 ± 0.2 2.8 ± 0.4 —
Progesterone receptor IC50 (24 hr) > 15 5.0 ± 0.9 —
Estrogen receptor EC50 (24 hr) 12 ± 4 NE (≤ 12.5) —
Estrogen receptor IC50 (24 hr) NE (≤ 12.5) 0.45 ± 0.03 —
Human TTR (Hamers et al. 2006) TTR binding (T4 competition) IC50 (binding equilibrium) > 25 0.18 —
Human TTR (Marchesini et al. 2008) TTR binding (T4 competition; biosensor) IC50 (binding equilibrium) NR (≤ 1) 0.087 NR (1.8)
Human TBG (Marchesini et al. 2008) TBG binding (T4 competition; biosensor) IC50 (binding equilibrium) NR (≤ 10) 0.11 NR (10)
Zebrafish (van Boxtel et al. 2008) Abnormal development EC50 (72 hr) NE (≤ 10) 0.025 NE (≤ 10)
Mortality (adult) EC50 (96 hr) NE (≤ 0.5) 0.3 —
Neurotransmitter receptors expressed in Xenopus 
oocytes (Hendriks et al 2010)
GABAA-receptor full agonism LOEC (20 sec) NE (≤ 10) 10 —
GABAA-receptor partial agonism LOEC (10 sec) NE (≤ 10) 10 —
nACh-receptor antagonism LOEC (5 sec) NE (≤ 10) 10 —
Rat PC12 cells (Dingemans et al. 2010a) Induction of [Ca2+]i oscillations LOEC (20 min) 2 0.2 NE (≤ 20)
Ca2+ release from intracellular stores LOEC (20 min) NE (≤ 20) 1 NE (≤ 20)
Abbreviations: —, not investigated; EC50, half-maximal effect concentration; GABAA, γ-aminobutyric acid-A; IC50, half-maximal inhibitory concentration; LOEC, lowest observed effect 
concentration; nACh, nicotinic acetylcholine; NE, no effect; NR, not reached; ROS, reactive oxygen species; TBG, T4-binding globulin. Neurotoxicity of PBDEs and OH-PBDEs
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Neurotoxicity of PBDEs: Cellular 
and Molecular Mechanisms
Cell viability. In several in vitro studies, tetra- 
and pentaBDEs were found to induce apop-
totic cell death in primary neurons or neuronal 
cell lines, which appeared to be a consequence 
of oxidative stress (Giordano et al. 2008; He 
et al. 2008; Madia et al. 2004; Reistad et al. 
2006; Yu et al. 2008). Recently, the fully bro-
minated BDE-209 was also shown to increase 
apoptotic cell death and oxidative stress in 
rat primary hippocampal neurons (Chen 
et al. 2010). This effect may not be specifi-
cally neuro  toxic, but neuronal cells are par-
ticularly vulnerable to oxidative stress because 
relatively high levels of reactive oxygen species 
(ROS) are generated during normal metabo-
lism and neuronal activity. It appears that the 
anti  oxidant capacity of enzymes that are able 
to react with and inactivate ROS is exceeded 
after exposure to PBDEs, resulting in oxida-
tive stress and subsequent damage of DNA, 
proteins, and membrane lipids.
Cell differentiation and migration. 
Differentiation and migration are critical pro-
cesses in neuro  development. During in vitro 
exposure to BDE-209, neurite outgrowth 
and the differentiation of neural stem cells 
into neurons were dose-dependently inhib-
ited [lowest observed effect concentration 
(LOEC), 10 μM]. Instead, a larger propor-
tion of the neural stem cells differentiated 
into glial cells (Zhang et al. 2010). In another 
study, Schreiber et al. (2010) observed a 
decrease in the number of cells differentiat-
ing to neuron-like or oligodendrocyte-like 
cell types when human neural progenitor cells 
were exposed to 1 μM BDE-47 or BDE-99. 
Moreover, these in vitro experiments demon-
strated decreased migration of human neu-
ral progenitor cells exposed to BDE-47 or 
BDE-99 (Schreiber et al. 2010), confirming 
previously suggested functional effects on cell 
migration, based on proteomics studies (Alm 
et al. 2008). In cultured fetal rat cortical cells, 
BDE-99–induced changes were also detected 
in levels of proteins involved in formation of 
the cyto  skeleton that is involved in cellular 
migration (Alm et al. 2010). 
Neuronal signaling. PBDEs (mainly tetra- 
and pentaBDEs) have been shown to affect 
several aspects of inter- and intra  neuronal sig-
naling, including inhibition of neuro  transmitter 
uptake in synapto  somes and neuro  transmitter 
vesicles and alterations in calcium (Ca2+) 
homeo  stasis (Kodavanti and Ward 2005; 
Mariussen and Fonnum 2003). DE-71 has 
recently been shown to reduce synapto  somal 
dopamine levels and increase medium dop-
amine concentrations in a system with isolated 
rat striatal synapto  somes, probably by inhibi-
tion of the membrane dopamine transporter 
(Dreiem et al. 2010). In addition to effects on 
neuro  transmitter uptake, BDE-47 (20 μM) 
induced vesicular neuro  transmitter release by 
exo  cytosis in PC12 pheochromo  cytoma cells 
(Dingemans et al. 2007). Importantly, the 
BDE-47 metabolite 6-OH-BDE-47 (5 μM) 
induced a more pronounced increase in exo-
cytosis in PC12 cells within several min-
utes after the start of exposure (Dingemans 
et al. 2008). The observed increases in exo-
cytosis were paralleled by increases in intra-
cellular calcium concentration ([Ca2+]i). At 
2 μM, BDE-47 induced only subtle changes in 
Ca2+ homeo  stasis that manifested as increased 
frequency and duration of fluctuations in 
[Ca2+]i, whereas no effects were observed 
on [Ca2+]i when PC12 cells were exposed to 
BDE-49 (2,2´,4,5´-tetra  brominated diphe-
nyl ether), BDE-99, BDE-100 (2,2´,4,4´,6-
penta  brominated diphenyl ether), or BDE-153 
(Dingemans et al. 2010a). On the other 
hand, 6-OH-BDE-47 (6-hydroxy-2,2´,4,4´-
tetrabrominated diphenyl ether; ≥ 1 μM) 
caused a rapid, robust increase in [Ca2+]i by 
release from endo  plasmic reticulum followed 
by release from mitochondria. Similar effects 
were detected for other OH-PBDEs [6-MeO-
BDE-47 (6-methoxy-2,2´,4,4´-tetrabrominated 
diphenyl ether) showed no effect]; although 
the potency to disturb calcium homeo  stasis 
depended on the presence of large atomic 
groups (bromine atom or aromatic ring) adja-
cent to the OH, the hydroxylation position was 
of lesser importance (Dingemans et al. 2010a). 
Although release of calcium from intra  cellular 
stores was not detected during exposure to par-
ent PBDEs, DE-71, BDE-47, and BDE-99 
have been shown to inhibit uptake of Ca2+ in 
microsomes and mitochondria isolated from rat 
cortex, cerebellum, and hippo  campus (Coburn 
et al. 2008). BDE-47 and OH-PBDEs that 
increased basal [Ca2+]i subsequently inhibited 
the depolarization-evoked increase in [Ca2+]i in 
PC12 cells at similar LOECs (Dingemans et al. 
2010b). Although this appeared to be a direct 
inhibitory effect on calcium entry, it was 
strongly potentiated by preceding increases in 
basal [Ca2+]i before depolarization, suggesting 
additional Ca2+-dependent regulatory mecha-
nisms (Dingemans et al. 2010b).
PBDEs have also been shown to affect sev-
eral aspects of intra  cellular signaling pathways 
that are involved in Ca2+ homeo  stasis and 
Ca2+ signaling (García et al. 2006) by inducing 
protein kinase C trans  location and arachidonic 
acid release via phospho  lipase A activation 
(Kodavanti and Derr-Yellin 2002; Kodavanti 
and Ward 2005; Madia et al. 2004). In cere-
bellar granule neurons, PBDE congeners and 
commercial mixtures (low micromolar range) 
also activated the mitogen-activated protein 
kinase pathway (Fan et al. 2010), which is 
involved in the modulation of various cellu  lar 
functions and in turn is modulated by both 
protein kinase C and Ca2+ (Pearson et al. 
2001; Schönwasser et al. 1998).
BDE-209 dose-dependently decreased volt-
age-gated sodium channel currents in primary 
rat hippocampal neurons (Xing et al. 2010). 
Recently, full and partial agonistic effects on 
the γ-aminobutyric acid-A (GABAA) recep-
tor and antagonistic effects on the α4β2 nico-
tinic acetylcholine (nACh) receptor (expressed 
in Xenopus oocytes) were demonstrated for 
6-OH-BDE-47, whereas these effects were not 
observed for BDE-47 (Hendriks et al. 2010). 
Because inter  actions of GABAergic, cholinergic, 
and glutaminergic neuro  transmitters are critical 
for the develop  ment of neuronal networks dur-
ing brain develop  ment (Ben-Ari et al. 2007), 
these opposite effects on excitatory (nACh) 
and inhibitory (GABA) neuro  transmitter 
receptor effects suggest an important role of 
the OH-PBDEs in the observed in vivo neuro-
toxicity of PBDEs.
Together, these in vitro studies indicate that 
lower brominated PBDEs (tetra- and penta-
BDEs) affect all levels of neuro  transmission, 
from presynaptic neuro  transmitter homeo  stasis, 
intra  cellular signaling, and neuro  transmitter 
release to post  synaptic neuro  transmitter recep-
tors. For some neuro  toxic end points, it is evi-
dent that OH-PBDEs have a higher potency 
than their parent congeners (Table 2), whereas 
this is unclear for other end points. Because 
intra  cellular signaling pathways, calcium 
homeo  stasis, and oxidative stress are inter-
related, the main molecular target of (OH-)
PBDEs remains unclear. However, the combi-
nation of results from several studies showing 
oxidative stress or mitochondrial Ca2+ release 
(or inhibition of Ca2+ uptake) suggests that 
mitochondria are a primary target for PBDE 
toxicity. This is supported by the observation 
of accumulation of PBDEs in mitochondria in 
mouse primary neurons (Huang et al. 2010). 
A combination of the observed cellular and 
molecular mechanisms could be involved in the 
observed neuro  behavioral impairments. In par-
ticular, OH-PBDEs have been shown to alter 
neuro  transmitter release patterns and under-
lying (Ca2+) signaling pathways. Influence 
of transient alterations in [Ca2+]i on brain 
develop  ment is not unlikely, because Ca2+ sig-
nals are essential in (early) brain development 
(for reviews, see Moody and Bosma 2005; 
Spitzer 2006) and the induction of synaptic 
plasticity (for reviews, see Malenka and Nicoll 
1999; Soderling and Derkach 2000). Small 
changes in catecholaminergic modulation can 
have effects on behavior (Arnsten and Li 2005). 
Temporary alterations of neuronal activity 
during critical periods in brain develop  ment 
could therefore under  lie the observed effects on 
behavior and hippo  campal synaptic plasticity. 
The concentrations at which effects of parent 
PBDEs are observed in vitro are very differ-
ent from human exposure levels. However, 
few in vitro studies take into account the low 
solubility of PBDEs or the binding of PBDEs Dingemans et al.
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to serum proteins and cell culture materials, 
resulting in over  estimation of cellu  lar expo-
sure concentrations. In contrast, accumulation 
into cells has also been demon  strated to occur, 
resulting in the possible under  estimation of 
intra  cellular PBDE concentrations after (sub)
chronic exposure (Huang et al. 2010; Mundy 
et al. 2004).
Conclusion and Discussion
Behavioral studies clearly indicate the neuro-
toxic potential of PBDEs. Importantly, several 
mechanistic studies indicate that this neuro-
toxic potential is higher for the OH-PBDEs. 
At least two effects of PBDEs or their metabo-
lites are expected to be involved in develop-
mental neuro  toxicity, resulting in structural 
and functional alterations in the brain and, 
ultimately, behavioral effects (Figure 1). On 
the one hand, direct toxic effects on the (devel-
oping) nervous system are likely involved in 
PBDE-induced developmental neuro  toxicity. 
On the other hand, PBDEs have been shown 
to affect the thyroid hormone system. Because 
thyroid hormones are critically involved in 
(early) brain development (for reviews, see 
Horn and Heuer 2010; Howdeshell 2002), 
this mechanism is likely involved in the 
PBDE-induced neuro  toxicity.
In humans, thyroid hormone production 
starts at approximately 10 weeks of gestation 
and increases with the development of the 
fetal hypothalamic–pituitary–thyroid axis 
(reviewed by Howdeshell 2002). However, 
trans  placental transfer of maternal thyroid 
hormones to the fetus is critical for neuro-
development. Impaired psycho  motor devel-
opment and visuo  spatial processing have been 
revealed in children born to mothers with 
(sub  clinical) hypothyroidism (Haddow et al. 
1999; Pop et al. 1999). Prenatal and postnatal 
hypo  thyroidism are associated with behavioral 
deficits in humans as well as animal models 
(reviewed by Zoeller and Rovet 2004). 
On a cellular level, effects of thyroid hor-
mones have been shown to be involved in 
neuronal proliferation, migration, synapto-
genesis, synaptic plasticity, and myelation 
processes (for reviews, see Horn and Heuer 
2010; Howdeshell 2002). Interestingly, sev-
eral of these processes (described above) have 
been shown to be directly affected by PBDEs 
or their metabolites, and adverse effects com-
parable to those observed after develop  mental 
exposure to BFRs are also observed in animal 
models of moderate or transient insufficiency 
in thyroid hormone levels, commonly induced 
by exposure to propyl  thiouracil (reviewed by 
Zoeller and Crofton 2005).
In vitro studies with 6-OH-BDE-47 
show that effect concentrations for displace-
ment of T4 from the hormone transport 
protein TTR and induction of [Ca2+]i oscil-
lations are within the same order of mag-
nitude (~ 0.2 μM; Table 2). Several animal 
studies have simultaneously investigated 
both PBDE-induced neuro  toxicity and 
effects on thyroid hormone levels. In rodents 
in which neonatal exposure to DE-71 and 
BDE-209 caused effects on neuro  behavior, 
hypo  thyroidism was also observed (Driscoll 
et al. 2009; Rice et al. 2007). Experimentally 
induced hypo  thyroidism has been shown to 
result in a decrease in cholinergic nerve end-
ings (Sawin et al. 1998). Therefore, the dis-
ruption of normal brain development by 
(OH-)PBDE-induced hypo  thyroidism may 
be an under  lying mechanism for the observed 
PBDE-induced alterations in the cholinergic 
neuro  transmitter system in rodents. However, 
other mechanisms are likely involved, because 
thyroid hormone levels were not affected 
in mice exposed at PND10 to a single oral 
dose of BDE-47, which is known to result 
in behavioral effects (Gee et al. 2008). On 
the other hand, for rat dams and offspring 
with very low levels of T4 after developmental 
exposure to DE-71, an effect was detected in 
only one of several behavioral tests (Kodavanti 
et al. 2010). This indicates that other mecha-
nisms are also involved in PBDE-induced 
behavioral neuro  toxicity, and that these may 
differ for various (behavioral) neuro  toxic end 
points and timing of exposure. Further inves-
tigation is required to determine the relative 
contributions or possible effect additivity of 
the direct and indirect (via thyroid disrup-
tion) neuro  toxic effects of (OH-)PBDEs in 
humans. Future studies on thyroid disrup-
tion also have to take into account that thy-
roid hormone levels within brain tissue are 
more informative of possible thyroid-related 
Figure 1. Direct and indirect PBDE-induced developmental neurotoxicity. Observed end points for which 
larger effects have been detected for OH-PBDEs are shown in blue.
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effects, because cellu  lar actions of thyroid 
hormones are initiated at nuclear receptors 
(reviewed by Cheng et al. 2010).
The binding of PBDEs and especially 
OH-PBDEs to receptors and transport pro-
teins involved in thyroid homeo  stasis and 
function is the expected mode of action of 
PBDE-induced hypothyroidism (Marchesini 
et al. 2008; Meerts et al. 2000; Schriks et al. 
2006; Ucán-Marín et al. 2009). However, 
other inter  actions with the thyroid system, 
for example, inhibition of iodine uptake 
such as observed for perchlorate (reviewed 
by Jugan et al. 2010), are also possible and 
require further study. It has been revealed 
only recently that BDE-209 inhibits thyroid-
hormone–induced dendrite arborization of 
rat Purkinje cells, probably via partial disso-
ciation of thyroid receptors from the binding 
domain on the thyroid-receptor–responsive 
element (Ibhazehiebo et al. 2010). It is com-
monly assumed that up-regulation of thyroid- 
stimulating hormone and deiodinase activity 
in the brain compensates for reductions in 
brain T4 levels. However, it has recently been 
revealed that compensatory mechanisms do 
not prevent effects on thyroid hormone tar-
gets in the brain resulting from small reduc-
tions in serum T4 (Sharlin et al. 2010).
Various environmental pollutants can dis-
rupt thyroid homeo  stasis (reviewed by Jugan 
et al. 2010). Especially if effects on thyroid 
homeostasis coincide with direct neuro  toxicity, 
as observed for PBDEs, develop  mental neuro-
toxicity has to be anticipated. Iodine deficiency, 
a common condition worldwide (reviewed by 
Walker et al. 2007), is an additional risk fac-
tor to increase the sensitivity to adverse effects 
from thyroid-disrupting chemicals.
Because of the strict temporal regulation 
of brain development processes, certain time 
windows are particularly sensitive to neuro-
toxic insults. Although brain development 
in humans extends into early childhood, the 
perinatal period of brain develop  ment (“brain 
growth spurt”; last trimester to 1–2 years of 
age) has especially been proven to be very sensi-
tive to neuro  toxic effects (reviewed by Rice and 
Barone 2000). It is currently difficult to esti-
mate whether gestational or lactational expo-
sure is most relevant for (OH-)PBDE-induced 
develop  mental neuro  toxicity in humans. The 
lower exposure during a sensitive (possibly 
prenatal) develop  mental phase may be more 
hazardous for the developing fetal brain than 
higher exposure during the next (possibly post-
natal) developmental phase via for example, 
lactational transfer. Further research on neuro-
development and cognitive and behavioral 
function, in particularly with respect to disrup-
tion by external stimuli, including xeno  biotics, 
is therefore required.
Partitioning of PBDEs into the (fetal) 
brain is detected in wildlife (Basu et al. 2007; 
Gebbink et al. 2008; Montie et al. 2009) and 
toxico  kinetics studies, often by using radio-
labeled PBDEs (Örn and Klasson-Wehler 
1998; Riu et al. 2008; Staskal et al. 2006a, 
2006b). In contrast, recent experimental and 
wildlife studies have shown that OH-PBDEs 
are usually not detectable in brain, although 
OH-PBDEs were detected in brain and cere-
brospinal fluids of marine mammals (Gebbink 
et al. 2008; Montie et al. 2009; Zhang et al. 
2008). Nonetheless, it should be recognized 
that for some OH-PCBs, specific accumula-
tion in brain tissue occurs, which has been 
suggested to be associated with binding to 
TTR (Meerts et al. 2002; Morse et al. 1996). 
OH-PBDEs also strongly bind to TTR as 
well as to T4-binding globulin (TBG), which 
is the main transporter protein for thyroid 
hormones in humans across the blood–brain 
barrier (Marchesini et al. 2008). Because of 
the discrepancy between observations in wild-
life and toxico  kinetics studies with parent 
PBDEs, as well as the demon  strated accu-
mulating properties of the structurally related 
(OH-)PCBs, the potential of OH-PBDEs to 
enter the brain requires further study.
For most classes of chemicals, risk assess-
ment is based on exposure and hazard assess-
ment of single compounds, with the exception 
of the toxic equivalency approach for diox-
ins and dioxin-like compounds (van den Berg 
et al. 2006). In reality, however, the human 
exposure pattern includes a plethora of chemi-
cals, including environ  mental and dietary 
(OH-)PBDE exposure and those originating 
from systemic metabolic conversion. For the 
latter aspect, inter  individual differences com-
monly occur (Hong and Yang 1997). Because 
of the observed similarities in effects on neuro-
behavior and on acute in vitro effects related 
to neuronal signaling, there is a scien  tific 
rationale to use concentration addition as the 
default precautionary approach for risk assess-
ment of mixtures of PBDEs, PCBs, and their 
metabolites. Because of the possible additiv-
ity of these environmental pollutants at levels 
below effective concentrations of the individ-
ual congeners and because of the higher sensi-
tivity of the developing brain, mixture effects 
must be taken into account for human risk 
assessment for develop  mental neuro  toxicity 
and investigated further.
Although the use of PBDEs has been 
greatly reduced in most countries because of 
voluntary and legislative meas  ures, humans and 
wildlife will still be exposed to PBDEs and their 
metabolites for many years to come because 
of their environmental persistence and the 
fact that consumer products with these flame 
retardants are still present in many homes. This 
also underscores the necessity of implementing 
better hazard and risk assessment strategies for 
identifying human health risks of new chemi-
cals, such as novel halogenated flame retardants. 
More knowledge on oxidative metabolism and 
the possible bioactivation of PBDEs, the sensi-
tivity to neuro  toxicity during specific processes 
of brain development, the concentrations of 
(OH-)PBDEs in the brain, and the inter  actions 
between different environmental contaminants 
during simultaneous exposure is currently 
required to further improve the assessment of 
neuro  toxic risk of PBDEs, their metabolites, 
and related environmental contaminants.
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